Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FZ0Y6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,171
Award facts
- Contract value 100% obligated
- $22,171.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,171.39 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This firm fixed-price contract, issued on January 26, 2026, with an ultimate completion date of January 27, 2026, represents a non-set-aside, competitively awarded transaction. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally.
The supply of Ozempic, a diabetes management medication, aligns with DLA's broader mission to provide essential pharmaceutical commodities to military treatment facilities and veteran healthcare systems. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen Drug Corp maintains extensive experience fulfilling government medical procurement requirements across multiple therapeutic domains. The non-set-aside designation indicates this award was made through open competition, demonstrating the contractor's continued capability to meet federal pharmaceutical supply standards and pricing requirements for critical medications supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FZ0Y6?
SPE2DR26FZ0Y6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FZ0Y6 worth?
The government has obligated $22,171 on SPE2DR26FZ0Y6.
Is contract SPE2DR26FZ0Y6 an order under another contract?
Yes. SPE2DR26FZ0Y6 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FZ0Y6 competed?
The extent of competition for SPE2DR26FZ0Y6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award